Fortress Biotech, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Fortress Biotech, Inc. (FBIO) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- Fortress Biotech, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$958.00K, a 4661.90% decline year-over-year.
- Fortress Biotech, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$56.00K.
- Fortress Biotech, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $2.55M, a 43.61% decline year-over-year.
- Fortress Biotech, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$1.74M.
- Fortress Biotech, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.55M, a 347.76% decline from fiscal 2024.
- Fortress Biotech, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $624.00K, a 26.42% decline from fiscal 2023.
- Fortress Biotech, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $848.00K, a 67.32% decline from fiscal 2022.
- Fortress Biotech, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $2.60M, a 739.81% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 63 month | Increase (Decrease) in Prepaid Expense and Other Assets 87 month | Increase (Decrease) in Prepaid Expense and Other Assets 90 month | Increase (Decrease) in Prepaid Expense and Other Assets 93 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$958.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.01M 10-Q · filed 2026-08-13 | $1.54M derived: sum of 3 quarters · filed 2026-08-13 | -$205.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2026-03-31 | -$56.00K 10-Q · filed 2026-05-14 | $2.50M derived: sum of 2 quarters · filed 2026-05-14 | $753.00K derived: sum of 3 quarters · filed 2026-05-14 | $774.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $809.00K derived: sum of 2 quarters · filed 2026-03-31 | $830.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.55M 10-K · filed 2026-03-31 | ||||||||
| 2025-09-30 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$1.72M derived: sum of 2 quarters · filed 2026-08-13 | -$4.10M 10-Q · filed 2025-11-14 | $428.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$2.35M 10-Q · filed 2026-08-13 | $2.17M derived: sum of 3 quarters · filed 2026-08-13 | $106.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-03-31 | -$2.38M 10-Q · filed 2026-05-14 | $2.15M derived: sum of 2 quarters · filed 2026-05-14 | $85.00K derived: sum of 3 quarters · filed 2026-05-14 | -$3.32M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||
| 2024-12-31 | $4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.46M derived: sum of 2 quarters · filed 2026-03-31 | -$947.00K derived: sum of 3 quarters · filed 2026-03-31 | $624.00K 10-K · filed 2026-03-31 | ||||||||
| 2024-09-30 | -$2.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$5.47M derived: sum of 2 quarters · filed 2025-11-14 | -$3.90M 10-Q · filed 2025-11-14 | $162.00K derived: sum of 4 quarters · filed 2025-11-14 | ||||||||
| 2024-06-30 | -$3.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$1.84M 10-Q · filed 2025-08-14 | $2.23M derived: sum of 3 quarters · filed 2025-08-14 | $1.25M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||
| 2024-03-31 | $1.57M 10-Q · filed 2025-05-15 | $5.64M derived: sum of 2 quarters · filed 2025-05-15 | $4.66M derived: sum of 3 quarters · filed 2025-05-15 | $3.62M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||
| 2023-12-31 | $4.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.09M derived: sum of 2 quarters · filed 2025-03-31 | $2.05M derived: sum of 3 quarters · filed 2025-03-31 | $848.00K 10-K · filed 2025-03-31 | ||||||||
| 2023-09-30 | -$974.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$2.02M derived: sum of 2 quarters · filed 2024-11-14 | -$3.22M 10-Q · filed 2024-11-14 | $717.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||||||
| 2023-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$2.24M 10-Q · filed 2024-08-13 | $1.69M derived: sum of 3 quarters · filed 2024-08-13 | $2.30M derived: sum of 4 quarters · filed 2024-08-13 | ||||||||
| 2023-03-31 | -$1.20M 10-Q · filed 2024-05-15 | $2.73M derived: sum of 2 quarters · filed 2024-05-15 | $3.34M derived: sum of 3 quarters · filed 2024-05-15 | $2.74M derived: sum of 4 quarters · filed 2024-05-15 | ||||||||
| 2022-12-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $4.54M derived: sum of 2 quarters · filed 2024-03-28 | $3.94M derived: sum of 3 quarters · filed 2024-03-28 | $2.60M 10-K · filed 2024-03-28 | ||||||||
| 2022-09-30 | $607.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $3.00K derived: sum of 2 quarters · filed 2023-11-14 | -$1.34M 10-Q · filed 2023-11-14 | $1.82M derived: sum of 4 quarters · filed 2023-11-14 | ||||||||
| 2022-06-30 | -$604.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.95M 10-Q · filed 2023-08-14 | $1.22M derived: sum of 3 quarters · filed 2023-08-14 | $1.16M derived: sum of 4 quarters · filed 2023-08-14 | ||||||||
| 2022-03-31 | -$1.34M 10-Q · filed 2023-05-15 | $1.82M derived: sum of 2 quarters · filed 2023-05-15 | $1.76M derived: sum of 3 quarters · filed 2023-05-15 | $173.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||||||
| 2021-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.10M derived: sum of 2 quarters · filed 2023-03-31 | $1.51M derived: sum of 3 quarters · filed 2023-03-31 | $309.00K 10-K · filed 2023-03-31 | ||||||||
| 2021-09-30 | -$59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.65M derived: sum of 2 quarters · filed 2022-11-14 | -$2.85M 10-Q · filed 2022-11-14 | $2.17M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||
| 2021-06-30 | -$1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$2.79M 10-Q · filed 2022-08-11 | $2.22M derived: sum of 3 quarters · filed 2022-08-11 | $725.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||||||
| 2021-03-31 | -$1.21M 10-Q · filed 2022-05-12 | $3.81M derived: sum of 2 quarters · filed 2022-05-12 | $2.31M derived: sum of 3 quarters · filed 2022-05-12 | $991.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||||||
| 2020-12-31 | $5.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $3.52M derived: sum of 2 quarters · filed 2022-03-28 | $2.20M derived: sum of 3 quarters · filed 2022-03-28 | $2.59M 10-K · filed 2022-03-28 | ||||||||
| 2020-09-30 | -$1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$2.82M derived: sum of 2 quarters · filed 2021-11-15 | -$2.43M 10-Q · filed 2021-11-15 | -$2.42M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||
| 2020-06-30 | -$1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$930.00K 10-Q · filed 2021-08-16 | -$916.00K derived: sum of 3 quarters · filed 2021-08-16 | $618.00K derived: sum of 4 quarters · filed 2021-08-16 | ||||||||
| 2020-03-31 | $393.00K 10-Q · filed 2021-05-17 | $407.00K derived: sum of 2 quarters · filed 2021-05-17 | $1.94M derived: sum of 3 quarters · filed 2021-05-17 | $1.08M derived: sum of 4 quarters · filed 2021-05-17 | ||||||||
| 2019-12-31 | $14.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-09 | $1.55M derived: sum of 2 quarters · filed 2021-04-09 | $685.00K derived: sum of 3 quarters · filed 2021-04-09 | -$1.80M 10-K/A · filed 2021-04-09 | ||||||||
| 2019-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $671.00K derived: sum of 2 quarters · filed 2020-11-09 | -$1.81M 10-Q · filed 2020-11-09 | -$3.24M derived: sum of 4 quarters · filed 2020-11-09 | ||||||||
| 2019-06-30 | -$863.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$3.35M 10-Q · filed 2020-08-10 | -$4.77M derived: sum of 3 quarters · filed 2020-08-10 | -$4.08M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||
| 2019-03-31 | -$2.48M 10-Q · filed 2020-05-11 | -$3.91M derived: sum of 2 quarters · filed 2020-05-11 | -$3.22M derived: sum of 3 quarters · filed 2020-05-11 | -$3.95M derived: sum of 4 quarters · filed 2020-05-11 | ||||||||
| 2018-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$737.00K derived: sum of 2 quarters · filed 2020-03-16 | -$1.46M derived: sum of 3 quarters · filed 2020-03-16 | $3.00K 10-K · filed 2020-03-16 | ||||||||
| 2018-09-30 | $688.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$38.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.43M 10-Q · filed 2019-11-12 | $562.00K 10-Q · filed 2018-11-09 | $4.01M derived: sum of 4 quarters · filed 2019-11-12 | |||||||
| 2018-06-30 | -$726.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $740.00K 10-Q · filed 2019-08-09 | $1.21M 10-Q · filed 2018-08-09 | $3.33M derived: sum of 3 quarters · filed 2019-08-09 | $2.16M derived: sum of 4 quarters · filed 2019-08-09 | |||||||
| 2018-03-31 | $1.47M 10-Q · filed 2019-05-10 | $1.94M 10-Q · filed 2018-05-10 | $4.05M derived: sum of 2 quarters · filed 2019-05-10 | $2.89M derived: sum of 3 quarters · filed 2019-05-10 | $6.11M derived: sum of 4 quarters · filed 2019-05-10 | |||||||
| 2017-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $1.42M derived: sum of 2 quarters · filed 2019-03-18 | $4.65M derived: sum of 3 quarters · filed 2019-03-18 | $4.01M 10-K · filed 2019-03-18 | $3.48M 10-K · filed 2018-03-16 | |||||||
| 2017-09-30 | -$1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $2.06M derived: sum of 2 quarters · filed 2018-11-09 | $1.43M 10-Q · filed 2018-11-09 | $833.00K derived: sum of 4 quarters · filed 2018-11-09 | ||||||||
| 2017-06-30 | $3.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.59M 10-Q · filed 2018-08-09 | $2.00M derived: sum of 3 quarters · filed 2018-08-09 | $2.99M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||
| 2017-03-31 | -$635.00K 10-Q · filed 2018-05-10 | -$1.23M derived: sum of 2 quarters · filed 2018-05-10 | -$236.00K derived: sum of 3 quarters · filed 2018-05-10 | -$597.00K derived: sum of 4 quarters · filed 2018-05-10 | ||||||||
| 2016-12-31 | -$593.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $399.00K derived: sum of 2 quarters · filed 2018-03-16 | $38.00K derived: sum of 3 quarters · filed 2018-03-16 | $204.00K 10-K · filed 2018-03-16 | ||||||||
| 2016-09-30 | $992.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $631.00K derived: sum of 2 quarters · filed 2017-11-09 | $797.00K 10-Q · filed 2017-11-09 | $1.21M derived: sum of 4 quarters · filed 2018-03-16 | ||||||||
| 2016-06-30 | -$361.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$195.00K 10-Q · filed 2017-08-09 | $219.00K derived: sum of 3 quarters · filed 2018-03-16 | $291.00K derived: sum of 4 quarters · filed 2018-03-16 | ||||||||
| 2016-03-31 | $166.00K 10-Q · filed 2017-05-10 | $580.00K derived: sum of 2 quarters · filed 2018-03-16 | $652.00K derived: sum of 3 quarters · filed 2018-03-16 | $927.00K derived: sum of 4 quarters · filed 2018-03-16 | ||||||||
| 2015-12-31 | $414.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $486.00K derived: sum of 2 quarters · filed 2018-03-16 | $761.00K derived: sum of 3 quarters · filed 2018-03-16 | $739.00K 10-K · filed 2018-03-16 | $895.00K 10-K · filed 2016-03-15 | |||||||
| 2015-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $347.00K derived: sum of 2 quarters · filed 2016-11-09 | $325.00K 10-Q · filed 2016-11-09 | $394.00K 10-Q · filed 2015-11-09 | $418.00K derived: sum of 4 quarters · filed 2017-03-16 | |||||||
| 2015-06-30 | $275.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $253.00K 10-Q · filed 2016-08-09 | $295.00K 10-Q · filed 2015-08-10 | $346.00K derived: sum of 3 quarters · filed 2017-03-16 | $501.00K derived: sum of 4 quarters · filed 2017-03-16 | |||||||
| 2015-03-31 | -$22.00K 10-Q · filed 2016-05-10 | $71.00K derived: sum of 2 quarters · filed 2017-03-16 | $226.00K derived: sum of 3 quarters · filed 2017-03-16 | $90.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||||||
| 2014-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $248.00K derived: sum of 2 quarters · filed 2017-03-16 | $112.00K derived: sum of 3 quarters · filed 2017-03-16 | $124.00K 10-K · filed 2017-03-16 | $139.00K 10-K · filed 2015-03-16 | |||||||
| 2014-09-30 | $155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $19.00K derived: sum of 2 quarters · filed 2015-11-09 | $31.00K 10-Q · filed 2015-11-09 | $262.00K derived: sum of 4 quarters · filed 2016-03-15 | ||||||||
| 2014-06-30 | -$136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$124.00K 10-Q · filed 2015-08-10 | $107.00K derived: sum of 3 quarters · filed 2016-03-15 | $143.00K derived: sum of 4 quarters · filed 2016-03-15 | ||||||||
| 2014-03-31 | $12.00K 10-Q · filed 2015-05-11 | $243.00K derived: sum of 2 quarters · filed 2016-03-15 | $279.00K derived: sum of 3 quarters · filed 2016-03-15 | $195.00K derived: sum of 4 quarters · filed 2016-03-15 | $582.00K 10-Q · filed 2014-05-12 | |||||||
| 2013-12-31 | $231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $267.00K derived: sum of 2 quarters · filed 2016-03-15 | $183.00K derived: sum of 3 quarters · filed 2016-03-15 | $117.00K 10-K · filed 2016-03-15 | $570.00K 10-K · filed 2014-03-14 | |||||||
| 2013-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$48.00K derived: sum of 2 quarters · filed 2014-11-06 | -$114.00K 10-Q · filed 2014-11-06 | -$200.00K derived: sum of 4 quarters · filed 2015-03-16 | $339.00K 10-Q · filed 2013-11-01 | |||||||
| 2013-06-30 | -$84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$150.00K 10-Q · filed 2014-08-11 | -$236.00K derived: sum of 3 quarters · filed 2015-03-16 | |||||||||
| 2013-03-31 | -$66.00K 10-Q · filed 2014-05-12 | -$152.00K derived: sum of 2 quarters · filed 2015-03-16 | ||||||||||
| 2012-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $238.00K 10-K · filed 2015-03-16 | ||||||||||
| 2012-09-30 | $324.00K 10-Q · filed 2013-11-01 | |||||||||||
| 2011-12-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $160.00K 10-K · filed 2014-03-14 | ||||||||||
| 2011-09-30 | $42.00K 10-Q · filed 2011-11-14 | $97.00K 10-Q · filed 2011-11-14 | ||||||||||
| 2010-09-30 | $201.00K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |